Skip to content
  • Company MedcoDRG
    • Cross Border Directive for Patients
    • Medical Tourism Trends in 2022 for Germany and the world
    • Customers of MedcoDRG
    • Founder of MedcoDRG
  • Our Services
    • Pricing and Ordering
  • Information for Patients
    • Medical Bill
    • Comparison of medical treatment costs in EU countries
  • News/Blog
    • Innovations/Medical Updates
    • European Commission
    • International Trends
    • Funding
    • Medical Education
    • Careers
    • Germany
    • Networking
  • Useful links
  • Contact
  • English
  • Deutsch
  • Русский
Menu Close
Search this website
  • Company MedcoDRG
    • Cross Border Directive for Patients
    • Medical Tourism Trends in 2022 for Germany and the world
    • Customers of MedcoDRG
    • Founder of MedcoDRG
  • Our Services
    • Pricing and Ordering
  • Information for Patients
    • Medical Bill
    • Comparison of medical treatment costs in EU countries
  • News/Blog
    • Innovations/Medical Updates
    • European Commission
    • International Trends
    • Funding
    • Medical Education
    • Careers
    • Germany
    • Networking
  • Useful links
  • Contact
  • English
  • Deutsch
  • Русский

Call 14 of the Innovative Medicines Initiative (IMI) is now open with topics on immune diseases, imaging, machine learning and digital clinical trials

  1. Home>
  2. Funding>
  3. Call 14 of the Innovative Medicines Initiative (IMI) is now open with topics on immune diseases, imaging, machine learning and digital clinical trials
You are currently viewing Call 14 of the Innovative Medicines Initiative (IMI) is now open with topics on immune diseases, imaging, machine learning and digital clinical trials

Call 14 of the Innovative Medicines Initiative (IMI) is now open with topics on immune diseases, imaging, machine learning and digital clinical trials

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry.

Call ID:   H2020-JTI-IMI2-2018-14-two-stage

Topics

• Topic 1: Targeted immune intervention for the management of non-response and relapse

• Topic 2: Non-invasive clinical molecular imaging of immune cells

• Topic 3: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery

• Topic 4: Centre of excellence – remote decentralised clinical trials

Stage 1 submission deadline: 14 June 2018

Read on: https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-14

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • More
  • Click to print (Opens in new window)
  • Click to share on Pocket (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on Skype (Opens in new window)

Like this:

Like Loading...

Related

  • Post author:Admin
  • Post published:May 25, 2018
  • Post category:Funding
  • Post comments:0 Comments

Private Policy

Legal Notice

Terms and Conditions

Sitemap

  • Opens in a new tab
  • Opens in a new tab
  • Opens in a new tab

©️ Copyright 2022 MedcoDRG

%d bloggers like this: